ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,099, issued on Dec. 9, was assigned to Epitomee Medical Ltd. (Caesarea, Israel).
"Intragastric expandable devices" was invented by Gil Cohen (Jerusalem), Valery Artamonov (Ashdod, Israel) and Dan Hashimshony (Pardes Hana, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a biodegradable device, administered to a patient in a compact ingestible encapsulated form. The device is self-expandable in the stomach upon contact with liquid, to assume an expanded, voluminous configuration within the stomach. The devices have a folded configuration in which intake is facilitated by the patient, and are designed to unfold and self-exp...